Small-Scale Bioreactors Market Set to Surge to USD 7.71 Billion by 2033 at a 14.8% of CAGR

A recent report by Future Market Insights (FMI) projects significant growth in the global small-scale bioreactors market, with an estimated valuation of USD 7.71 billion by 2033. The market, valued at approximately USD 1.94 billion in 2023, is anticipated to expand at a robust compound annual growth rate (CAGR) of 14.8% over the forecast period from 2023 to 2033.

Key factors driving this growth include increasing demand for scalable bioproduction processes, advancements in bioprocessing technologies, and the rising application of bioreactors in drug development, cell culture, and other biotechnology sectors. The industry’s accelerated trajectory reflects a broader shift toward innovative, efficient biomanufacturing solutions to meet evolving demands in pharmaceuticals, healthcare, and research.

This dynamic growth presents promising opportunities for stakeholders across the bioproduction spectrum, including biotechnology firms, research institutions, and healthcare providers, enabling advancements in therapeutic solutions and a more sustainable biomanufacturing landscape.

2018 to 2022 Small-scale Bioreactors Demand Outlook Compared to 2023 to 2033 Market Forecast

The market generated a revenue of US$ 1.69 billion in 2022. Looking forward, the market is set to register a CAGR of 14.8% to reach US$ 1.94 billion in 2023. By 2033 end, the market is anticipated to reach a market valuation of US$ 7.71 billion.

In the preceding years, especially 2020 and 2021, the market growth was marked by significant expansions of facilities. In order to carry out research and development for COVID-19 vaccines. The forecast period is going to witness more opportunities for the market to expand. Some common factors that are expected to positively influence the market include:

• Immunization campaigns across the globe.
• Significant investments by government bodies to enhance biopharmaceutical research and develop vaccines.
• The growing burden of chronic illnesses.

Key Companies Profiled

Sartorius AG; Thermo Fisher Scientific Inc.; Merck KGaA; Danaher Corporation; Lonza Group; Eppendorf AG; Miltenyi Biotec; Getinge AB; Solaris Biotechnology Srl; Infors AG

A Full Report Overview

Small-scale Bioreactors Market by Category

By Product, the Small-scale Bioreactors Industry is segmented as:

• Small-scale Reusable Bioreactors
  • Small-scale Stainless Steel Bioreactors
  • Small-scale Glass Bioreactors
• Small-scale Single-use Bioreactors

By Capacity, the Small-scale Bioreactors Industry is categorized as:

• Small-scale Bioreactors of 5 ML -100 ML Capacity
• Small-scale Bioreactors of 100 ML-250 ML Capacity
• Small-scale Bioreactors of 250 ML -500 ML Capacity
• Small-scale Bioreactors of 500 ML-1 L Capacity
• Small-scale Bioreactors of 1L-3L Capacity
• Small-scale Bioreactors of 3L-5L Capacity

By End User, the Small-scale bioreactors Market is segregated as:

• Small-scale Bioreactors for Pharmaceutical & Biopharmaceutical Companies
• Small-scale Bioreactors for CROs & CMOs
• Small-scale Bioreactors for Academic & Research Institutes

By Region, the Industry of Small-scale Bioreactors is segmented as:

• Small-scale Bioreactors in North America Market
• Small-scale Bioreactors in Europe Market
• Small-scale Bioreactors in Asia Pacific Market
• Small-scale Bioreactors in Latin America Market
• Small-scale Bioreactors in the Middle East and Africa Market

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube